Enclomiphene

Enclomiphene is a prescription-only compound, taken by mouth, that pushes the body to make more of its own testosterone. It is not an FDA-approved drug in the United States. No product carries a US label, so every version sold here is compounded, and compounded medicines are not reviewed by the FDA for safety, effectiveness or quality before they are sold.

That single fact shapes everything else on this page: the dosing, the price, the pharmacy, the monitoring plan and the legal footing all vary by program, because there is no official label setting a standard. This guide explains what the drug does, what the research actually shows, what can go wrong, and what a month of treatment tends to involve when you are paying cash.

What enclomiphene is, and why no version is FDA approved

Clomiphene citrate is an older fertility drug. It is a mixture of two mirror-image forms: enclomiphene, the more active anti-estrogen half, and zuclomiphene, a slower-clearing half that lingers in the body for weeks. Enclomiphene citrate is simply that first half, separated out. Both belong to a class called selective estrogen receptor modulators, or SERMs, which block estrogen signaling in some tissues while leaving it alone in others.

A pharmaceutical company developed a single-isomer enclomiphene capsule and ran late-stage trials in men with low testosterone. It never reached the market with an approved label. Public reporting on that program points to unresolved questions about trial design and about whether raising a testosterone number, by itself, proves that patients feel or function better. The development program stalled, and the compound has stayed unapproved since.

It is also not a supplement, whatever a website selling capsules implies. The Department of Defense supplement safety program is blunt on this point: clomiphene and enclomiphene are drugs, not dietary ingredients, and products marketing them as supplements are mislabeled.

What compounded means here

Because no approved product exists, pharmacies make the capsules from raw powder. Two categories do this: 503A pharmacies, which compound for one named patient at a time, and 503B outsourcing facilities, which make larger batches under stricter federal manufacturing rules. Neither route means FDA approval. The agency explains plainly that compounded drugs are not FDA approved or checked before sale.

There is a second wrinkle. Federal law limits which bulk ingredients a compounder may use, and FDA keeps public lists of nominated bulk drug substances under section 503A. Where a substance sits on those lists can change, and that decides whether pharmacies can keep compounding it. The legal footing for a single isomer that is not itself part of an approved medicine is less settled than for a substance pulled straight from an approved drug. Availability can therefore shift with policy, not just with supply.

How it works inside the male hormone loop

Testosterone production runs on a feedback loop between the brain and the testicles, often called the HPG axis. The hypothalamus releases pulses of a signal hormone. The pituitary answers with luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH. LH tells cells in the testicles to make testosterone. FSH supports sperm production. Some testosterone converts to estradiol, a form of estrogen, and estradiol tells the brain to ease off. That is the brake.

This SERM sits on estrogen receptors in the hypothalamus and pituitary and blocks that brake signal. The brain reads the estrogen level as low, so it pushes harder. LH and FSH rise, and the testicles respond by making more testosterone on their own. Review articles describe this mechanism in detail, including evidence that enclomiphene raises testosterone while maintaining sperm counts.

That is the practical difference from testosterone therapy. Injected or topical testosterone raises the hormone from outside, and the brain reacts by shutting the loop down. LH and FSH fall, the testicles get quiet, and sperm production usually drops, sometimes to zero. A drug that works through the pituitary keeps the loop switched on instead.

One consequence follows from the mechanism: it only works if the testicles can still respond. Men with secondary hypogonadism, where the signal from the brain is weak but the testicles are healthy, are the group studied. Men with primary testicular failure have a broken factory, and shouting louder at it does not help.

A note on doses you see online

Forums quote specific milligram strengths as though they were settled. They are not label-backed, because there is no label. Trials tested low daily oral doses, and compounding pharmacies produce several strengths. Dose selection, timing and length of use are decisions for a prescribing clinician working from your labs and symptoms, not from a message board.

What the research supports, and where it goes quiet

The strongest and most consistent finding is hormonal. Studies show total testosterone rising into the normal range in men with low levels, alongside higher LH and FSH. A 2024 systematic review and meta-analysis comparing the two SERMs reported that enclomiphene improved testosterone with a lower rate of documented adverse events than clomiphene.

Sperm preservation is the second finding, and it is the reason many younger men are steered here. Where testosterone gel or injections suppress sperm output, this approach generally does not, and in some men with impaired production it improves the numbers. That matters if you want children now or later.

Now the quiet part. Symptom data is thinner than hormone data. Some trials report better energy, libido and morning erections, but studies are relatively short and often small. There is no long-term evidence base on bone density, heart attacks, strokes, prostate outcomes or mortality for this specific compound. Nobody can tell you what ten years of daily use does, because nobody has run that study.

Treat the before-and-after photos and physique claims circulating online with the same caution. This is a hormone-signaling drug, not a body-composition drug, and results in a marketing gallery are not results from a trial. Our Independent Editorial Coverage takes the same line on any treatment where testimonial volume outruns published evidence.

Side effects men report most often

Most reported effects are mild and dose-related. In studies and clinical use, the ones that come up repeatedly are headache, nausea, hot flushes, mood swings or irritability, acne, breast tenderness, and testicular ache. Some men notice trouble sleeping. Because the drug raises testosterone, estradiol usually rises too, which can drive the breast tenderness and mood changes.

A smaller group of effects deserves more attention because they come from the SERM class as a whole:

• Visual disturbances. Blurred vision, spots, flashes or light sensitivity are recognized effects of clomiphene and are a reason to contact a clinician promptly rather than wait. Patient labeling for the parent drug lists vision changes among the effects that need medical attention.
• Blood clots. SERMs as a class carry a signal for venous thromboembolism. The absolute risk in healthy men appears low, but it is not zero, and personal or family clotting history changes the calculation.
• Mood and mental health. Hormone shifts can amplify anxiety, low mood or irritability. Any new or worsening thoughts of self-harm are an urgent reason to seek help.
• Red blood cell rise. Any therapy that lifts testosterone can thicken the blood. It is generally less pronounced than with injections, but hematocrit is still worth tracking.

Frequencies here are approximate. Without an approved label there is no official adverse-event table, and reported rates come from trials of different sizes and lengths.

Warnings, interactions and men who should skip it

Start with diagnosis. Low testosterone is confirmed with morning blood tests on more than one day, not with a symptom quiz. The American Urological Association guideline on testosterone deficiency sets out that diagnostic standard, including the need to look for underlying causes such as pituitary problems, sleep apnea, thyroid disease, opioid use or obesity. Treating a number without asking why it is low can hide a condition that needs its own treatment.

Caution or avoidance generally applies to men with a personal or family history of blood clots, active liver disease, untreated pituitary tumors, hormone-sensitive cancer, or unexplained visual problems. Men with primary testicular failure are unlikely to benefit. This drug is not used in men who are not deficient, and using it to boost normal levels is not a studied use.

Interactions worth flagging

Formal interaction studies are limited, which is itself a caution. The combinations most often discussed are:

• Testosterone gels, injections or pellets, which work against the mechanism by suppressing the same loop.
• Other SERMs or aromatase inhibitors used to control estradiol, which can push estrogen too low and cause joint pain, low libido and bone effects.
• Anticoagulants and other drugs affecting clotting, given the class clot signal.
• hCG and similar fertility agents, which stimulate the same pathway from a different angle.
• Anything that suppresses testosterone independently, such as long-term opioids or high-dose glucocorticoids.

Tell any prescriber your full list, including supplements sold for testosterone support, since several contain undisclosed pharmaceutical ingredients. Competitive athletes should also note that SERMs appear on the World Anti-Doping Agency prohibited list and are banned in and out of competition.

Monitoring that a serious program builds in

Expect baseline bloodwork before the first capsule and repeat testing after treatment starts. A reasonable panel usually includes total and free testosterone, LH, FSH, estradiol, a complete blood count for hematocrit, and PSA where age-appropriate. A semen analysis is relevant if fertility is the point. Vision changes, chest symptoms and mood shifts are checked by asking, not by a lab.

Comparing this SERM with clomiphene and with testosterone therapy

Men usually arrive at this page trying to settle one of two comparisons. Neither has a universal winner; the right answer depends on why your level is low, whether you want children, and how your body responds.

On the SERM comparison, the case for the single isomer is that it removes zuclomiphene, the half that hangs around for weeks and is blamed for much of the mood and visual trouble. The comparative meta-analysis supports a lower adverse event rate, though the trade-off is that the isomer has no approved product behind it while clomiphene tablets do.

On testosterone therapy, the honest framing is that replacement raises levels more reliably and faster, and has decades of clinical experience behind it. It also switches off your own production. The FDA has separately cautioned against using testosterone products for age-related low levels. If fertility is a live concern, that is usually the deciding factor.

What a month costs when you pay cash

Nearly every man taking this drug pays for it himself. Across the men’s health programs we track, the lowest recorded self-pay price for a plan including it is $99 a month, with a median around $114 across 2 tracked programs. Advertised prices move, so treat any figure as a snapshot rather than a promise.

What actually moves the monthly number:

• What the fee covers. Some programs quote one price covering the consult, the capsules and shipping. Others quote a membership and bill medication separately. Compare the total, not the headline.
• Labs. Baseline and follow-up bloodwork may be included, discounted, or entirely on you. This is the most common hidden cost.
• Pharmacy and strength. Compounded pricing varies by pharmacy and by capsule strength. Higher strengths often cost more.
• Intro versus renewal. A discounted first month that steps up at renewal is a common structure. Look for the ongoing rate.
• Billing period. Quarterly or half-year prepayment usually lowers the monthly figure and raises the amount at risk if you stop.

Because this is a daily medication people often take for many months, the annual figure is the one worth knowing before you commit.

Insurance and enclomiphene

Plans rarely pay for compounded drugs with no FDA-approved equivalent, and coverage for men’s hormone treatment is uneven even for approved products. Do not assume anything: call the number on your card, ask specifically about compounded preparations, and ask separately whether the diagnostic labs are covered, since those are often billable through your regular clinician even when the medication is not. Some men use HSA or FSA funds, subject to their plan rules. Never treat a marketing page as evidence of coverage.

If you are weighing several programs, our Free Savings Report shows how the same treatment can land at very different totals once labs and fees are counted, and our Patient Cost Calculators handle the arithmetic. Related compounds and their pricing patterns sit in the Medication Guide Index.

How telehealth programs differ on this treatment

Because there is no label to standardize care, the program you pick determines the quality of the care far more than it would with an approved drug. The differences that matter are not cosmetic.

• Labs before prescribing. Does the program require confirmed morning testosterone results before writing anything, or does it prescribe from a questionnaire? Two morning tests is the clinical standard.
• Follow-up testing. Ask when the first repeat panel happens and whether estradiol and hematocrit are included.
• Who prescribes. Some programs name the clinician and their specialty; others do not. Urology or endocrinology experience is meaningful here.
• Which pharmacy. Ask for the name and whether it is a 503A pharmacy or a 503B outsourcing facility, and whether the capsules are tested for potency.
• Fertility handling. If children are the goal, ask whether semen analysis is part of the plan.
• State availability and cancellation. Telemedicine prescribing rules are set state by state, and refund terms vary widely.

You can see which programs offer this treatment in the module on this page, and browse the wider market in our Telehealth Provider Directory. If you want to know how the ratings on those pages are built, the weighting is set out in our Provider Scoring Method.

Questions worth asking, and when to seek care

Bring these to a consultation, and be wary of any program that will not answer them in writing:

1. What did my labs show, and what is the likely cause of my low level?
2. Am I a candidate given my fertility plans and my clotting history?
3. What strength am I being prescribed, and why that one?
4. When will you retest, and which markers?
5. What happens if my estradiol climbs or my hematocrit rises?
6. What are the alternatives, including treating an underlying cause first?
7. What is the total monthly cost at renewal, including labs and shipping?
8. How do I stop safely, and what happens to my levels afterwards?

Contact a clinician promptly for new or worsening vision problems, persistent severe headache, breast lumps or marked tenderness, or a mood change that worries you or the people around you. Seek emergency care for chest pain, sudden shortness of breath, one-sided leg pain or swelling, weakness or trouble speaking, or an erection lasting more than four hours. Any thought of harming yourself is an emergency; in the US you can call or text 988.

Authoritative sources

• FDA, on human drug compounding and approval status.
• National Library of Medicine, patient information for clomiphene and its recognized effects.
• American Urological Association, the testosterone deficiency clinical guideline.

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.